11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Mirtazapin STADA

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Mirtazapin

Mirtazapin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H et al. Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol. 2015;35:250-9.

  2. Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, Diav-Citrin O et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry. 2006;67:1280-4.

  3. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004;113:368-375.

  4. Källén B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004;158:312-6.

  5. Andersson L, Sundström-Poromaa I, Wulff M, Åström M, Bixo M. Neonatal outcome following maternal antenatal depression and anxiety: A population based study. Amer J Epidemiol 2004;159:872-81.

  6. Costei AM, Kozer E, Ho T et al. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32.

  7. Yaris F, Kadioglu M, Kesim M, Ulku C, Yaris E, Kalyoncu NI. Newer antidepressants in pregnancy: prospective outcome of a case series. Reprod Toxicol 2004;19:235-8.

  8. Lennestål R, Källén B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol. 2007;27:607-13..

  9. McElhatton PR, Garbis HM, Eléfant E et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 1996;10:285-94.

  10. Ericson A, Källén B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999;55:503-8.

  1. Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H et al. Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol. 2015;35:250-9.
  2. Djulus J, Koren G, Einarson TR, Wilton L, Shakir S, Diav-Citrin O et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry. 2006;67:1280-4.
  3. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004;113:368-375.
  4. Källén B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004;158:312-6.
  5. Andersson L, Sundström-Poromaa I, Wulff M, Åström M, Bixo M. Neonatal outcome following maternal antenatal depression and anxiety: A population based study. Amer J Epidemiol 2004;159:872-81.
  6. Costei AM, Kozer E, Ho T et al. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32.
  7. Yaris F, Kadioglu M, Kesim M, Ulku C, Yaris E, Kalyoncu NI. Newer antidepressants in pregnancy: prospective outcome of a case series. Reprod Toxicol 2004;19:235-8.
  8. Lennestål R, Källén B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol. 2007;27:607-13..
  9. McElhatton PR, Garbis HM, Eléfant E et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 1996;10:285-94.
  10. Ericson A, Källén B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999;55:503-8.